Regeneron Pharmaceuticals News Timeline

Regeneron Pharmaceuticals -- USA Stock  

USD 314.13  1.88  0.59%

This is yet another view into Regeneron Pharmaceuticals filtered headlines to help investors concentrate on Regeneron Pharmaceuticals noise-free news that matters. Some academic researchers believe in strong correlation between financial news and their impacts to the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Regeneron Pharmaceuticals headlines in addition to utilizing other more conventional financial analysis modules. Additionally take a look at Regeneron Pharmaceuticals Backtesting and Regeneron Pharmaceuticals Hype Analysis.
Macroaxis News
March 14, 2018
Exercise or conversion by Joshua Boger of 4400 shares of Vertex Pharmaceuticals subject to Rule 16b-3 at MacroaxisInsider 
View Story
news
April 23, 2018
Massive Volume Gainers Vertex Pharmaceuticals Incorporateds at www.getstocksnews.com 
View Story
Macroaxis News
March 12, 2018
Exercise of in-the-money or at-the-money derivative position by Kelso Equity Partners V L P of 836 shares of Endo International at MacroaxisInsider 
View Story
Macroaxis News
March 13, 2018
Sale by Roger Bird of 200 shares of Abbott Laboratories at MacroaxisInsider 
View Story
news
April 23, 2018
Heres What Day Traders Should Know Allergan plc at alphabetastock.com 
View Story
Macroaxis News
March 27, 2018
Acquisition by Nicholson C David2 of 8835 shares of Allergan plc subject to Rule 16b-3 at MacroaxisInsider 
View Story
Macroaxis News
April 23, 2018
Bio Rad exotic insider transaction detected at MacroaxisInsider 
View Story
Macroaxis News
April 23, 2018
Bristol Myers exotic insider transaction detected at MacroaxisInsider 
View Story
wsj  News
March 8, 2018
Few Things investors Didnt Know About Bristol-Myers Squibb Company , US Bancorp at www.stocknewsjournal.com 
View Story
Macroaxis News
April 23, 2018
Sale by Lilly Endowment Inc of 800 shares of Eli Lilly at MacroaxisInsider 
View Story
news
April 3, 2018
Analysts who cover Eli Lilly and Company rated it a consensus rating score of 2.2 at www.analystrecommendation.com 
View Story
news
March 6, 2018
Mallinckrodt Public Limited Company recently purchased by insider Youngblood Dr Kneeland at postanalyst.com 
View Story
Macroaxis News
March 13, 2018
Acquisition by Thier Samuel O Md of 988 shares of Merck subject to Rule 16b-3 at MacroaxisInsider 
View Story

Did you try this?

Run Cryptocurrency Correlation Now
   

Cryptocurrency Correlation

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins and exchanges
View All  Next Launch Cryptocurrency Correlation

Trending Equities

Currently Active Assets on Macroaxis
F   
 NYQ 
Purchased over 200 shares of
2 days ago
Traded for 10.96
MSFT   
 NMS 
Purchased over 30 shares of
2 days ago
Traded for 96.11
GM   
 NYQ 
Purchased over 70 shares of
2 days ago
Traded for 37.77
DD   
 NYQ 
Purchased over 100 shares of
2 days ago
Traded for 30.6
CRM   
 NYQ 
Purchased over 20 shares of
2 days ago
Traded for 124.06
RKDA   
 NCM 
Purchased over 100 shares of
2 days ago
Traded for 23.82
Additionally take a look at Regeneron Pharmaceuticals Backtesting and Regeneron Pharmaceuticals Hype Analysis. Please also try Portfolio Manager module to state of the art portfolio manager to monitor and improve performance of your invested capital.